Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1995 1
1997 1
1998 5
1999 1
2000 1
2001 1
2002 2
2003 1
2005 1
2007 2
2008 3
2009 2
2011 3
2012 5
2013 2
2014 4
2020 2
2021 3
2022 4
2023 10
2024 3
2025 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trial.
Knowler WC, Doherty L, Edelstein SL, Bennett PH, Dabelea D, Hoskin M, Kahn SE, Kalyani RR, Kim C, Pi-Sunyer FX, Raghavan S, Shah VO, Temprosa M, Venditti EM, Nathan DM; DPP/DPPOS Research Group. Knowler WC, et al. Lancet Diabetes Endocrinol. 2025 Jun;13(6):469-481. doi: 10.1016/S2213-8587(25)00022-1. Epub 2025 Apr 28. Lancet Diabetes Endocrinol. 2025. PMID: 40311647 Clinical Trial.
Genomics-informed drug-repurposing strategy identifies two therapeutic targets for preventing liver disease associated with metabolic dysfunction.
Seagle HM, Akerele AT, DeCorte JA, Hellwege JN, Breeyear JH, Kim J, Levin MG, Khodursky S, Bress A, Lee KM, Meiler J, Gill D, Lee JS, Heberer K, Miller DR, Reaven PD, Chang KM, Lynch JA; VA Million Veteran Program; Khankari NK, Shuey MM, Edwards TL, Vujkovic M. Seagle HM, et al. Am J Hum Genet. 2025 Aug 7;112(8):1778-1791. doi: 10.1016/j.ajhg.2025.06.014. Am J Hum Genet. 2025. PMID: 40780050 Free PMC article.
Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH.
Li JH, Brenner LN, Kaur V, Figueroa K, Schroeder P, Huerta-Chagoya A; MAGIC Investigators; Diabetes Prevention Program (DPP) Research Group; Udler MS, Leong A, Mercader JM, Florez JC. Li JH, et al. Diabetologia. 2023 Jul;66(7):1260-1272. doi: 10.1007/s00125-023-05922-7. Epub 2023 May 26. Diabetologia. 2023. PMID: 37233759 Free PMC article.
Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
Naggie S, Boulware DR, Lindsell CJ, Stewart TG, Gentile N, Collins S, McCarthy MW, Jayaweera D, Castro M, Sulkowski M, McTigue K, Thicklin F, Felker GM, Ginde AA, Bramante CT, Slandzicki AJ, Gabriel A, Shah NS, Lenert LA, Dunsmore SE, Adam SJ, DeLong A, Hanna G, Remaly A, Wilder R, Wilson S, Shenkman E, Hernandez AF; Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV-6) Study Group and Investigators. Naggie S, et al. JAMA. 2022 Oct 25;328(16):1595-1603. doi: 10.1001/jama.2022.18590. JAMA. 2022. PMID: 36269852 Free PMC article. Clinical Trial.
Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial.
Evering TH, Moser C, Jilg N, Ritz J, Wohl DA, Li JZ, Margolis D, Javan AC, Eron JJ, Currier JS, Daar ES, Smith DM, Hughes MD, Chew KW; ACTIV-2/A5401 Study Team. Evering TH, et al. EClinicalMedicine. 2024 Aug 16;75:102787. doi: 10.1016/j.eclinm.2024.102787. eCollection 2024 Sep. EClinicalMedicine. 2024. PMID: 39252866 Free PMC article.
Sociodemographic, Clinical, and Psychosocial Predictors of Short- and Long-term Study Retention in the Diabetes Prevention Program (DPP) Outcomes Study (DPPOS).
Tjaden AH, Braffett BH, Butera NM, Araneta MR, Carmichael O, Groessl EJ, Hazuda HP, Hoskin MA, Ibebuogu U, Magee MF, Mau M, Stich T, Soliman D, Wallia A, Temprosa M, Golden SH; Diabetes Prevention Program Research Group. Tjaden AH, et al. Diabetes Care. 2025 Oct 1;48(10):1685-1694. doi: 10.2337/dc25-0520. Diabetes Care. 2025. PMID: 40541257 Free PMC article. Clinical Trial.
Analysis of Long-term Follow-up of a Randomized Clinical Trial With Departures From Assigned Treatments: Estimation of Metformin Effects on Diabetes and Its Complications in the Diabetes Prevention Program Outcomes Study.
Knowler WC, Pan Q, Shu S, Tripputi MT, Dabelea D, Edelstein SL, Kahn SE, Kuo S, Luchsinger JA, Shah V, Wallia A, Temprosa M; Diabetes Prevention Program Research Group. Knowler WC, et al. Diabetes Care. 2025 Oct 1;48(10):1668-1675. doi: 10.2337/dci25-0032. Diabetes Care. 2025. PMID: 40857175 Free PMC article. Clinical Trial.
Nonglycemic and Glycemic Risk Factors for Painful Neuropathic Symptoms and for Distal Symmetrical Polyneuropathy (DSPN) in the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study.
Herman WH, Ciarleglio A, Callaghan BC, Edelstein SL, Goldberg R, White NH, Albers JW; Diabetes Prevention Program Research Group. Herman WH, et al. Diabetes Care. 2025 Oct 1;48(10):1676-1684. doi: 10.2337/dc25-0596. Diabetes Care. 2025. PMID: 40532190 Free PMC article. Clinical Trial.
64 results